Article Text

Download PDFPDF
The stomach periglandular fibroblast sheath: all present and correct
  1. S J Leedham,
  2. M Brittan,
  3. S L Preston,
  4. S A C McDonald,
  5. N A Wright
  1. Histopathology Unit, Cancer Research UK, London, UK
  1. Correspondence to:
    Dr S Leedham
    Histopathology Unit, Cancer Research UK, 44 Lincoln’s Inn Fields, London WC2A 3PX, UK; simon.leedham{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We were interested in the paper by Mutoh and colleagues1 showing the development of epithelial intestinal metaplasia and mesenchymal proliferation in human stomach resections and Cdx2 transgenic mice. The authors used α smooth muscle actin (α-SMA) staining to mark periglandular fibroblasts and failed to show any α-SMA positive cells surrounding the en face glands of normal mouse and human stomach mucosa. In metaplastic tissue however, the periglandular fibroblast sheath was easily discernible, and the authors concluded that the fibroblast sheath was generated from the intestinal submucosa, possibly through expression of Cdx2.

Mesenchymal cells such as intestinal subepithelial myofibroblasts (ISEMF) are widely distributed. They are important coordinating cells that possess significant influence on their environment by virtue of their receptor profile and the signals they produce. Characteristically, ISEMF form a protective fenestrated sheath around the stem cell compartment, creating the stem cell niche—the optimal microenvironment for stem cells to give rise to differentiated …

View Full Text


  • Grant support was provided by the Medical Research Council Clinical Research Fellowship.

  • Conflict of interest: None declared.